Monetarism Compared to Soviet Central Planning A Critical Economic Perspective Singapore Unveils Refreshed Retail Industry Digital Plan with Emphasis on AI Solutions Waterfield Advisors Equities Head Views Peak Macro Concerns as Potentially Behind Advocates Staggered Approach Gold and Silver Prices Decline as Precious Metals Face Continued Pressure Oil Markets Near Minimum Operating Levels in Asia Warns Carlyles Jeff Currie USS George Washington Departs Yokosuka Geopolitical Implications for IndoPacific Security and Defense Markets Evergy Q1 2026 Earnings EPS Beats Estimates with 458 Surprise First Citizens BancShares Inc FCNCA Q1 2026 Earnings Robust Earnings Beat Reflects Strong Operating Execution OFS Credit Company OCCI Q1 2026 Earnings Massive EPS Miss Sends Stock Lower Sandisk Q1 2026 Earnings EPS Soars Past Estimates Yet Stock Declines TIGO Q1 2026 Earnings EPS Misses Estimates by Wide Margin Stock Declines 33 DCH Q1 2026 Earnings Massive EPS Surprise Propels Stock Higher Grove Collaborative Holdings GROV Inches Higher as Stock Hovers Near Resistance TFS Financial Corporation TFSL Trades Near Support Amid Modest Decline Compugen CGEN Surges 728 as Shares Approach Key Resistance Level CDTTW Warrants Remain Static at 001 Analysis of Current Stalemate Ultra Clean Holdings UCTT Gains 26 as Shares Approach Key Resistance Level Keysight Technologies KEYS Holds Above Support After Measured Gain HACQU Edges Lower as SPAC Unit Continues to Trade Near 10 Level CRA International CRAI Edges Higher Navigating Key Support and Resistance Levels Cohu Inc COHU Surges 578 on Strong Momentum Key Levels to Watch ConAgra Brands CAG Stages Modest Rebound Testing Key Resistance at 1400 Bernstein Initiates Coverage on Six Indian Pharma Stocks Highlights AI and Innovation as Key Drivers KVYO Q1 2026 Earnings EPS Surprises by 102 as Stock Gains 37 CII Holds Steady at 2479 as Price Action Remains RangeBound Addentax Group Corp ATXG Q1 2025 Earnings Narrowing Loss Amid Limited Disclosure Stock Gains TEVA Q1 2026 Earnings EPS Beats Estimates by 878 as Generic Drugmaker Posts Strong Quarter KMPR Q1 2026 Earnings EPS Falls 74 Short of Estimates Amid Underwriting Challenges GIII Q1 2026 Earnings EPS Falls Short Amid Challenging Retail Environment Annovis Bio Q1 2026 Earnings EPS Misses Estimates but Shares Rally on Pipeline Optimism PDS Biotechnology Q1 2026 Earnings EPS Beat and Clinical Progress Highlight PreRevenue Quarter GTES Q1 2026 Earnings EPS Beat Driven by Operational Efficiency and Demand